MarketPeel
Insider Trading Intelligence
Pricing
…
PB

Padmanabh P. Bhatt

SUPN
SR. VP OF IP, CSO · SUPERNUS PHARMACEUTICALS, INC. · CIK 0001539215
FILING MIX · LIFETIME44%/56%
BUYS
63
SELLS
79
TOTAL VALUE
$17.86M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
0
AVG SELL PX
$41.38
TRADE KIND
SHOWING 142 / 142
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
24 backtested trades · 8 horizons · 25 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Padmanabh P. Bhatt, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d24+54.17%-0.37%+0.06%-0.43%-0.55%—
14d24+58.33%-0.15%-0.14%-0.01%-0.70%—
30d24+70.83%-4.88%+0.76%-5.65%-5.16%—
60d24+45.83%-4.06%+2.12%-6.18%-9.18%—
90d24+83.33%-11.26%+4.01%-15.28%-16.76%—
180d24(6 pending)+77.78%-7.20%+7.39%-14.59%-13.38%—
1y24(7 pending)+64.71%-3.15%+13.92%-17.08%-17.96%—
2y24(12 pending)+25.00%+28.98%+41.22%-12.24%+9.70%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SUPN · 0 shares · as of Mar 18, 2026
016,76133,52250,28367,044202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 63 buys / 79 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
7,250$39.40$285.6K24,294Mar 18, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
412$50.48$20.8K17,044Mar 18, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,838$49.55$338.8K17,456Mar 18, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
7,250——0Mar 18, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
15,000——5,000Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
12,250——0Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
22,290$50.73$1.13M17,044Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
27,710$49.95$1.38M39,334Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
15,000$38.60$579.0K67,044Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
12,250$36.75$450.2K52,044Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
22,750$39.40$896.4K39,794Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
22,750——7,250Mar 17, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
4,250$29.61$125.8K44,044Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
5,000——15,000Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
15,886$50.49$802.1K17,044Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
22,750——12,250Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
4,250——0Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
18,000——0Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
34,114$50.18$1.71M32,930Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
5,000$27.94$139.7K67,044Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
18,000$32.20$579.6K62,044Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
22,750$36.75$836.1K39,794Mar 16, 2026Mar 18, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
650$50.69$32.9K17,044Feb 25, 2026Feb 26, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——17,694Feb 25, 2026Feb 26, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——1,250Feb 25, 2026Feb 26, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,125——3,375Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,125——16,025Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
646$50.86$32.9K16,444Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
354$50.86$18.0K15,840Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——17,090Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——2,500Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
750——0Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
581$51.35$29.8K15,444Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
750——16,194Feb 24, 2026Feb 25, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Feb 18, 2026Feb 20, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,500——13,500Feb 18, 2026Feb 20, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
1,500——15,218Dec 18, 2025Dec 19, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
710$44.44$31.6K14,508Dec 18, 2025Dec 19, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,500——0Dec 18, 2025Dec 19, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,500——1,500Nov 13, 2025Nov 14, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
1,250——14,299Aug 25, 2025Aug 27, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——0Aug 25, 2025Aug 27, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
581$41.46$24.1K13,718Aug 25, 2025Aug 27, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——1,250Aug 7, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
575$33.05$19.0K12,704Mar 5, 2025Mar 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
575$33.05$19.0K13,279Mar 5, 2025Mar 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
335$33.05$11.1K13,854Mar 5, 2025Mar 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——14,189Feb 23, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——2,500Feb 23, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
750——750Feb 22, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——3,750Feb 22, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——12,939Feb 22, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
750——11,689Feb 22, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
1,650——11,799Feb 21, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,650——0Feb 21, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
860$39.15$33.7K10,939Feb 21, 2025Feb 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Feb 19, 2025Feb 21, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,500——4,500Feb 19, 2025Feb 21, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
9,477$39.70$376.2K10,149Feb 4, 2025Feb 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
9,477——4,250Feb 4, 2025Feb 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
9,477$29.61$280.6K19,626Feb 4, 2025Feb 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
700——13,727Jan 28, 2025Feb 5, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,650——1,650Jan 28, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
700——9,477Jan 28, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
700$29.61$20.7K10,849Jan 28, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
700$39.62$27.7K10,149Jan 28, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
2,573——10,177Jan 27, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
2,573$29.61$76.2K12,722Jan 27, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,573$39.62$101.9K10,149Jan 27, 2025Jan 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
8,750——0Dec 3, 2024Dec 4, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
12,745——0Dec 3, 2024Dec 4, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
12,745$36.68$467.5K9,679Dec 3, 2024Dec 4, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
8,750$36.68$320.9K9,679Dec 3, 2024Dec 4, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
12,745$25.30$322.4K22,424Dec 3, 2024Dec 4, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
8,750$23.99$209.9K18,429Dec 3, 2024Dec 4, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
572$29.57$16.9K9,679Aug 20, 2024Aug 20, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
1,250——10,251Aug 20, 2024Aug 20, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——0Aug 20, 2024Aug 20, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——1,250Aug 1, 2024Aug 14, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
14,491$35.31$511.7K8,570Mar 21, 2024Mar 25, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
14,491——12,745Mar 21, 2024Mar 25, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
14,491$25.30$366.6K23,061Mar 21, 2024Mar 25, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
400——27,236Mar 20, 2024Mar 22, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
400$25.30$10.1K8,970Mar 20, 2024Mar 22, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
400$35.31$14.1K8,570Mar 20, 2024Mar 22, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
12,364$25.30$312.8K20,934Mar 19, 2024Mar 21, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
12,364$35.31$436.6K8,570Mar 19, 2024Mar 21, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
12,364——27,636Mar 19, 2024Mar 21, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
26,250$34.10$895.1K8,570Mar 13, 2024Mar 15, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
26,250——8,750Mar 13, 2024Mar 15, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
36,116$33.48$1.21M8,570Mar 13, 2024Mar 15, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
36,116$12.98$468.8K44,686Mar 13, 2024Mar 15, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
36,116——0Mar 13, 2024Mar 15, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
26,250$23.99$629.7K34,820Mar 13, 2024Mar 15, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
3,884$12.98$50.4K12,454Mar 12, 2024Mar 14, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
3,884——36,116Mar 12, 2024Mar 14, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,884$32.99$128.1K8,570Mar 12, 2024Mar 14, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$30.21$151.1K8,570Feb 26, 2024Feb 28, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
5,000$9.13$45.6K13,570Feb 26, 2024Feb 28, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
5,000——0Feb 26, 2024Feb 28, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
638$29.06$18.5K8,570Feb 23, 2024Feb 27, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,250——9,208Feb 23, 2024Feb 27, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,250——3,750Feb 23, 2024Feb 27, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
750——8,330Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
750——1,500Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
372$27.94$10.4K7,958Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
2,500——8,347Sep 7, 2023Sep 7, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
2,500——0Sep 7, 2023Sep 7, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
1,182$32.10$37.9K7,165Sep 7, 2023Sep 7, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,500——2,500Aug 23, 2023Aug 25, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
750——5,497May 11, 2023May 12, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
750——0May 11, 2023May 12, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
750——750May 4, 2023May 8, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,500——4,747Apr 11, 2023Apr 12, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Feb 23, 2023Feb 27, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Feb 23, 2023Feb 27, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
750——3,247Feb 22, 2023Feb 24, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
750——2,250Feb 22, 2023Feb 24, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
4,826——5,000Jan 17, 2023Jan 19, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
4,826$9.13$44.1K6,470Jan 17, 2023Jan 19, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
4,826$39.92$192.6K1,644Jan 17, 2023Jan 19, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
174$39.90$6.9K1,644Jan 6, 2023Jan 9, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
174$9.13$1.6K1,818Jan 6, 2023Jan 9, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
174——9,826Jan 6, 2023Jan 9, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
5,000——10,000Dec 1, 2022Dec 2, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
5,000$9.13$45.6K6,644Dec 1, 2022Dec 2, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
5,000$37.48$187.4K1,644Dec 1, 2022Dec 2, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
6,800$9.24$62.8K8,444Nov 11, 2022Nov 15, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
6,800$34.95$237.7K1,644Nov 11, 2022Nov 15, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
6,800——0Nov 11, 2022Nov 15, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
700$34.97$24.5K1,644Nov 9, 2022Nov 14, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Sr. VP of IP, CSO
700$9.24$6.5K2,344Nov 9, 2022Nov 14, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Sr. VP of IP, CSO
700——6,800Nov 9, 2022Nov 14, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
750——1,644Jul 15, 2022Aug 5, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Feb 22, 2022Feb 24, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,000——18,000Feb 22, 2022Feb 24, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,000——18,000Feb 22, 2022Feb 25, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Feb 22, 2022Feb 25, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,000——17,000Feb 19, 2021Feb 23, 2021 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 21, 2020Feb 25, 2020 ↗View →
Other insiders · SUPN
Loading peer insiders…
About this filer
CIK 0001539215
ROLE
Sr. VP of IP, CSO
PRIMARY
SUPN
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001539215DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback